S3Z-51007-85869 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-23
Dose 1 — Pfizer-BioNTech
2021-02-13
Dose 2 — Pfizer-BioNTech
2021-03-04
Registered in v-safe
2021-03-04
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2022-02-14
Survey response — 12 months, dose 2
MedDRA: COVID-19, Conjunctivitis, Staphylococcal infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: COVID pink eye and staph infection

MedDRA releases: 2024-11 · check-in free text available
2022-02-14
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-15
Call successful
Does not wish to fill out VAERS report

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-23	Pfizer-BioNTech
2	2021-02-13	Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — 12 months, dose 2

2022-02-14

Symptoms: COVID pink eye and staph infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	COVID-19	·	·	✓
SD	Staphylococcal infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release